Lupin gets tentative USFDA nod for Fosaprepitant injection Farhat Nasim8 May 2019 10:00 AM ISTFosaprepitant for injection is a generic version of Merck Sharp & Dohme Corp's Emend for injection in the same strength.New Delhi: Drug firm Lupin...
Biocon commercial rights on biosimilar adalimumab extends to global markets Farhat Nasim8 May 2019 9:45 AM ISTBiocon, under the terms of its global partnership with Mylan for monoclonal antibodies, retains its economic interest in this expanded in-licensing...
Alembic Pharma partners with SPH Group, Adia for Chinese market Garima8 May 2019 9:30 AM ISTSPH Sine, Alembic Pharma and Adia will hold 51 per cent, 44 per cent and 5 per cent equity in the JVA.Vadodara: City-based Alembic Pharmaceuticals has...
Glenmark appoints Yasir Rawjee as CEO of Glenmark Life Sciences Medical Dialogues Bureau8 May 2019 9:15 AM ISTYasir Rawjee joins Glenmark Life Sciences from Mylan, where most recently he was the Head of Global API Operations, Glenmark Pharmaceuticals said in a...
NPPA to revise ceiling price of Silver Sulphadiazine cream 1 pc; direct manufacturers to furnish data Meghna A Singhania7 May 2019 4:52 PM ISTNew Delhi: Through a recent Office Memorandum, National Pharmaceutical Pricing Authority (NPPA) has informed that it will soon revise the ceiling...
Alembic Pharma JV gets EIR from USFDA for Karakhadi facility Farhat Nasim7 May 2019 10:10 AM ISTThe EIR is for the inspection carried out by USFDA at Alembic Pharma's joint venture, Aleor Dermaceuticals' at Karakhadi, Gujarat, India during the...
Merck will now be called Procter & Gamble Health Farhat Nasim7 May 2019 10:05 AM ISTMerck has received approval from the Registrar of Companies, Mumbai, Maharashtra, for change of name from Merck Ltd to Procter & Gamble Health Ltd...
Pfizer gets USFDA nod for potential blockbuster heart drug Tafamidis Medical Dialogues Bureau7 May 2019 9:45 AM ISTPfizer, which has touted tafamidis as a potential blockbuster product, set a list price of $225,000 a year for the medicine, which would be sold under...
Jacobus Pharma wins USFDA approval for Ruzurgi to treat rare autoimmune disorder Medical Dialogues Bureau7 May 2019 9:25 AM ISTThe drug, Ruzurgi, was approved for use in patients aged between 6 and 17, the FDA said Lambert-Eaton myasthenic syndrome, which affects about three...
Medlife acquires medicine delivery startup Myra Medicines Garima7 May 2019 9:00 AM ISTMyra's acquisition will enable the company to strengthen its pharma business and accrue profits, Medlife said in a statement.New Delhi: Health-tech...
DOP Order: NPPA refixes retail price of Trilosar 6.25, 12.5 Meghna A Singhania6 May 2019 11:23 AM ISTNew Delhi: Through a recent notification, the government regulatory agency, the National Pharmaceutical Pricing Authority (NPPA) has fixed the retail...
Dr Reddys launches generic version of AndroGel in US market Farhat Nasim6 May 2019 10:15 AM ISTThe company's testosterone gel 1.62 per cent, which is a therapeutic equivalent generic version of AndroGel 1.62 per cent of AbbVie Inc, was approved...
